SCHEMBL2835923

SCHEMBL2835923

COC(=O)c1ccc(C(=O)Nc2ccccc2)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.81
RAB9A P51151 6/20 0.73
SMN1; SMN2 Q16637 4/20 0.70
MEN1 O00255 4/20 0.70
KMT2A Q03164 4/20 0.70
NPC1 O15118 4/20 0.70
ATM Q13315 1/20 0.70
POLB P06746 1/20 0.70
L3MBTL1 Q9Y468 1/20 0.70
ALDH1A1 P00352 3/20 0.66
LMNA P02545 2/20 0.66
HTT P42858 1/20 0.66
HDAC2 Q92769 1/20 0.65
HDAC8 Q9BY41 1/20 0.65
HDAC6 Q9UBN7 1/20 0.65
TSHR P16473 1/20 0.64
GAA P10253 2/20 0.64
PKM P14618 1/20 0.63
MAPT P10636 2/20 0.63
PSMD14 O00487 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL62930 0.95 PTPN1 (0.90) PTPN1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL8660366 0.90 NPC1 (0.83) PTPN1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL6263820 0.90 NPC1 (0.83) PTPN1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL2835618 0.90 PTPN1 (0.94) PTPN1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL29611669 0.90 PTPN1 (0.94) PTPN1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL22223650 0.90 PTPN1 (0.94) PTPN1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL11710023 0.87 RAB9A (0.76) PTPN1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL2834528 0.87 PTPN1 (0.73) PTPN1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL1315526 0.86 PTPN1 (0.87) PTPN1RAB9AMEN1KMT2ANPC1
SCHEMBL4112603 0.85 MEN1 (0.75) PTPN1RAB9ASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117945822-B Reductive amidation method of triazine ester and nitroaromatic hydrocarbon 南京工业大学 2025-01-10 CN disclosed
CN-117945822-A Reductive amidation method of triazine ester and nitroaromatic hydrocarbon 南京工业大学 2024-04-30 CN disclosed
EP-3049469-B1 NUCLEATING AGENT FOR THERMOPLASTIC POLYMER COMPOSITION MILLIKEN & CO (US) 2018-05-30 EP disclosed
EP-2940000-B1 PROCESS FOR PREPARING METHYL ACETATE DALIAN INST CHEMICAL PHYSICS CAS (CN) 2017-10-18 EP disclosed
US-9440226-B2 Method for preparing methyl acetate DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) 2016-09-13 US disclosed
EP-2940000-A1 PROCESS FOR PREPARING METHYL ACETATE Dalian Institute Of Chemical Physics, Chinese Academy of Sciences (CN) 2015-11-04 EP disclosed
US-20150298108-A1 METHOD FOR PREPARING METHYL ACETATE DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) 2015-10-22 US disclosed
US-20100168101-A1 OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2010-07-01 US disclosed
US-7696231-B2 Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPs) LABORATOIRES SERONO SA (CH) 2010-04-13 US disclosed
EP-1660437-B1 HYDROXAMIC ACID DERIVATIVES AND THE METHOD FOR PREPARING THEREOF AMOREPACIFIC CORP (KR) 2008-10-15 EP disclosed
WO-2005019162-A1 HYDROXAMIC ACID DERIVATIVES AND THE METHOD FOR PREPARING THEREOF AMOREPACIFIC CORPORATION (KR) 2005-03-03 WO disclosed
US-20050043388-A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. 2005-02-24 US disclosed
EP-1439834-A1 OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) Applied Research Systems ARS Holding N.V. (AN) 2004-07-28 EP disclosed
WO-2003037328-A1 OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2003-05-08 WO disclosed
EP-1218336-A2 MELANIN CONCENTRATING HORMONE ANTAGONIST Takeda Chemical Industries, Ltd. (JP) 2002-07-03 EP disclosed
WO-2001021577-A2 MELANIN CONCENTRATING HORMONE ANTAGONIST TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-03-29 WO disclosed
US-5672750-A Preparation of aromatic amides from carbon monoxide, an amine and an aromatic chloride EASTMAN CHEMICAL COMPANY (US) 1997-09-30 US disclosed
EP-0564250-A2 Structured liquid detergent compositions containing amido and imido peroxy acids UNILEVER PLC (GB) 1993-10-06 EP disclosed
US-4128554-A Process for the preparation of carboxylic acid amides from organic halides UNIVERSITY OF DELAWARE (US) 1978-12-05 US disclosed
US-3988358-A Process for the preparation of carboxylic acid esters from organic halides THE UNIVERSITY OF DELAWARE (US) 1976-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150298108-A1 METHOD FOR PREPARING METHYL ACETATE EHMT2, EHMT1, DNMT1 PTPN1 4839/4885RAB9A 3401/4885SMN1; SMN2 837/4885
US-20050043388-A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) PTPRO, PTPRE, PTPRZ1 PTPN1 16/4885RAB9A 3219/4885SMN1; SMN2 4885/4885
US-20100168101-A1 OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) PTPRO, PTPRE, PTPRZ1 PTPN1 16/4885RAB9A 3161/4885SMN1; SMN2 4885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.